A.K. Singh et al. / Journal of Organometallic Chemistry 694 (2009) 3084–3090
3089
anol (2 ꢄ 10 mL), diethyl ether (2 ꢄ 10 mL) and dried under vac-
uum. Yield: 157 mg, 80%. Anal. Calc. for C34H40N2O2Cl2Rh2: C,
51.99; H, 5.13; N, 3.57. Found: C, 51.82; H, 5.15; N, 3.66%. UV–
C–H), 171.2 (coordinated C–H), 156.7, 142.4 (C, PPh3), 138.4,
131.3, 130.1, 125.7, 125.5, 121.2 (C, aromatic), 96.8 (C, C5Me5),
8.9 (CH3, C5Me5). 31P NMR (CDCl3, d ppm): 16.09, ꢁ137 (sep.).
Vis. {CH2Cl2, k nm (
e
)}: 511 (5.01 ꢄ 103), 424 (1.29 ꢄ 104), 313
UV–Vis. {CH2Cl2, k nm (
e
)}: 463 (1.66 ꢄ 104), 338 (1.51 ꢄ 104),
(1.25 ꢄ 104). FAB-MS: m/z 749 (750), [M]ꢁCl, 40%; 477 (476),
262 (2.37 ꢄ 104). IR (cmꢁ1, KBr pellet): 1597 (
mC@N), 1530 (mC@C),
[M]ꢁ[(
g
5-C5Me5)RhCl]ꢁCl, 35%.
1465 (
m
C@N), 1437 (
m
P–Ph), 1305 (dO–H), 1269 (
m
N–N), 1196 (
m
C–O),
1152 (
m
C–O), 842 (
m
P–F), 755 (dC–Hph), 679 (dC–H).
3.2.2. Preparation of [{(
It was prepared following the above procedure adopted for 1
except that [{( -Cl}2] (200 mg, 0.25 mmol) was
5-C5Me5)IrCl(
used in place of [{( -Cl}2]. Yield: 195 mg, 81%.
5-C5Me5)RhCl(
g j
5-C5Me5)IrCl}2( 2-bsh)] 2
3.2.6. Preparation of complex [(
g
5-C5Me5)Ir(AsPh3)(
j
2-Hbsh)]PF6
6
g
l
It was prepared following the procedure adopted for 5, using
AsPh3 in place of PPh3. Yield: 221 mg, 87%. Anal. Calc. for
C42H41N2O2PAsIrF6: C, 49.60; H, 4.04; N, 2.76. Found: C, 49.68; H,
3.98; N, 2.73%. 1H NMR (CDCl3, d ppm): 9.99 (s, 1H), 7.68 (s, 1H),
7.42 (s, 1H), 7.35 (s, 1H), 7.31–7.24 (m, 15H, AsPh3), 7.03 (d, 1H,
J = 8.1 Hz), 6.72 (t, 2H, J = 7.2 Hz), 6.56 (t, 2H, J = 7.5 Hz), 6.39 (s,
1H), 1.46 (s, 15H, C5Me5). 13C NMR (CDCl3, d ppm): 161.7 (free
C–H), 172.6 (coordinated C–H), 155.4, 141.2 (C, PPh3), 133.9,
132.7, 130.2, 130.1, 127.2, 121.4 (C, aromatic), 95.8 (C, C5Me5),
9.0 (CH3 C5Me5).
g
l
Anal. Calc. for C34H40N2O2Cl2Ir2: C, 42.36; H, 4.18; N, 2.91. Found:
C, 42.30; H, 4.15; N, 3.06%. 1H NMR (CDCl3, d ppm): 9.69 (s), 7.39
(d, J = 7.8 Hz), 7.31–7.24 (m), 7.03 (d, J = 8.4 Hz), 6.61 (t,
J = 7.2 Hz), 1.43 (s). UV–Vis. {CH2Cl2, k nm (
e
)}: 511 (6.02 ꢄ 103),
480 (4.87 ꢄ 103), 346 (7.91 ꢄ 103), 311 (1.24 ꢄ 104), 262
(1.62 ꢄ 104). FAB-MS: m/z 928 (928), [M]ꢁCl, 50%; 565 (566),
[M]ꢁ[(
g
5-C5Me5)IrCl]ꢁCl, 75%.
3.2.3. Preparation of complex [(g j 3
5-C5Me5)Rh(PPh3)( 2-Hbsh)]PF6
To a suspension of 1 (195 mg, 0.25 mmol) in methanol (25 mL),
PPh3 (65 mg, 0.25 mmol) and NH4PF6 (40 mg, 0.25 mmol) were
added and the contents of the flask were refluxed for 5 h. It was
cooled to room temperature and the reaction mixture was evapo-
rated to dryness under vacuum and the residue was extracted with
CH2Cl2. After filtration, the filtrate was saturated with petroleum
ether (60–80) and the solution left undisturbed in a refrigerator.
A microcrystalline product separated within a few hours. It was fil-
tered washed with diethyl ether, dried under vacuum and recrys-
tallized using dichloromethane/diethyl ether. Yeild: 188 mg, 85%
Anal. Calc. for C42H41N2O2P2RhF6: C, 57.01; H, 4.63; N, 3.16. Found:
C, 57.06; H, 4.65; N, 3.18%. 1H NMR (CDCl3, d ppm): 10.48 (s, 1H),
7.73 (s, 2H), 7.49 (d, 1H, J = 6.6 Hz), 7.45 (s, 1H) 7.31–7.24 (m,
15H, PPh3), 7.16 (d, 1H, J = 7.8 Hz), 7.07 (d, 1H, J = 8.4 Hz), 6.97 (t,
2H, J = 7.8 Hz), 6.86 (d, 1H, J = 6.6 Hz), 6.6 (t, 1H, J = 8.4 Hz), 1.37
(s, 15H, C5Me5). 13C{1H} NMR (CDCl3, d ppm): 162.9 (free C–H),
169.9 (coordinated C–H), 157.8, 134.6 (C, PPh3), 132.2, 130.4,
127.9, 127.8, 121.2, 115.8 (C, aromatic) 98.9 (C, C5Me5), 8.75
(CH3, C5Me5).31P NMR (CDCl3, d ppm): 30.7, ꢁ130.32 (sep.). UV–
3.2.7. Preparation of complex [(
Cl]PF6
To a solution of 3 [(obtained by stirring 3 (221 mg, 0.25 mmol)
and KOH (15 mg, 0.25 mmol,) in 25 mL of methanol)], [{(g6
C10H14)Ru( -Cl)Cl}2] (77 mg, 0.125 mmol) was added and stirred
g l-bsh) Ru(g )
5-C5Me5)RhCl( 6-C10H14
7
-
l
for 4 h at 50 °C. Slowly, it dissolved and a dark brown product sep-
arated which was filtered, washed with methanol (2 ꢄ 10 mL), dis-
tilled water (10 mL), methanol (2 ꢄ 10 mL), diethyl ether
(2 ꢄ 10 mL) and dried under vacuum. The crude product was puri-
fied by column chromatography Yield: 216 mg, 75%. Anal. Calc. for
C52H54N2O2ClRhRuP2F6: C, 54.10; H, 4.71; N, 2.43. Found: C, 53.92;
H, 4.77; N, 2.38%. (CDCl3, d ppm): 9.32 (br, s, 2H), 7.32–7.78 (m,
15H, PPh3), 7.14 (t, J = 6.9 Hz, 2H), 7.02 (t, J = 6.3 Hz, 2H), 6.93 (d,
J = 8.4 Hz, H), 6.51 (d, J = 7.8 Hz, 2H), 5.34 (m, 2H), 5.12 (m, 2H),
2.61 (m, 1H), 2.10 (s, 3H), 1.47 (s, 15H), 0.91 (d, J = 6.6 Hz, 6H).
ESI-MS: m/z 710.9 (711.6), [M]ꢁClꢁPF6ꢁPPh3, 8%; 477 (476),
[M]ꢁ[(g
6-C6H14)RuCl]ꢁClꢁPF6ꢁPPh3, 100%.
3.2.8. Preparation of complex [(
Cl]PF6
g l-bsh) Ru(g )
5-C5Me5)IrCl( 6-C10H14
Vis. {CH2Cl2, k nm (
e
)}: 486 (2.22 ꢄ 103), 415 (6.14 ꢄ 103), 345
8
(1.61 ꢄ 104), 268 (2.36 ꢄ 104), 246 (2.36 ꢄ 104). IR (cmꢁ1, KBr pel-
It was prepared following the above procedure adopted for 7,
except that 5 (243 mg, 0.25 mmol) was used in place of 3. Yield:
227 mg, 73%. Anal. Calc. for C52H54N2O2ClIrRuP2F6: C, 50.22; H,
4.38; N, 2.25. Found: C, 50.00; H, 4.15; N, 2.13%. 1H NMR (CDCl3,
d ppm): 9.66 (br, s, 2H), 7.36–7.82 (m, 15H, PPh3), 7.23 (t,
J = 8.1 Hz, 2H), 7.14 (t, J = 7.5 Hz, 2H), 7.03 (d, J = 7.5 Hz, H), 6.63
(d, J = 8.1 Hz, 2H), 5.77 (m, 2H), 5.42 (m, 2H), 2.78 (m, 1H), 2.23
(s, 3H), 1.39 (s, 15H), 1.01 (d, J = 6.9 Hz, 6H). ESI-MS: m/z 1208.2
(1209.0), [M]ꢁCl, 8%; 1063.2 (1066.9), [M]ꢁClꢁPF6, 15%;
801(802), [M]ꢁClꢁPF6ꢁPPh3, 40%.
let), 1597 mC@N), 1527 ( C@C), 1465 (mC@N), 1436 (mP–Ph), 1308 (dO–H),
m
1269 (mN–N), 1193 (mC–O), 1151 (mC–O), 842 (PF6), 757 (dC–Har) and
696 (dC–H).
3.2.4. Preparation of complex [(g j 4
5-C5Me5)Rh(AsPh3)( 2-Hbsh)]PF6
It was prepared by following the above procedure adopted for 3
except that AsPh3 was used in place of PPh3. Yield: 197 mg, 83%.
Anal. Calc. for C42H41N2O2PAsRhF6: C, 54.21; H, 4.41; N, 3.02.
Found: C, 54.26; H, 4.45; N, 3.06%. 1H NMR (CDCl3, d ppm): 10.23
(s, 1H), 7.65 (s, 2H), 7.38 (d, 1H, J = 6.3 Hz), 7.32 (s, 1H), 7.28–
7.12 (m, 15H AsPh3), 7.02 (d, 1H, J = 7.5 Hz), 6.95 (d, 1H,
J = 7.8 Hz), 6.82 (t, 2H, J = 8.1 Hz), 6.72 (d, 1H, J = 6.0 Hz), 6.55 (t,
2H, J = 8.1 Hz), 1.42 (s, 15H, C5Me5). 13C NMR (CDCl3, d ppm):
164.2 (free C–H), 169.8 (coordinated C–H), 154.6, 140.2 (C, PPh3),
135.2, 132.3, 130.3, 127.9, 127.4, 118.2 (C, aromatic), 99.3 (C,
C5Me5), 8.8 (CH3, C5Me5).
3.3. X-ray crystallography
Crystals suitable for single crystal X-ray data collection for 1
and 2 were obtained by slow diffusion of a deprotonated solution
of H2bsh in methanol into the dichloromethane solution of [{(g5
-
C5Me5)MCl(l-Cl}2] [M = Rh, Ir] and for 3 and 5 crystals were
obtained by slow diffusion using dichloromethane/diethyl ether.
X-ray data on 1, 2, 3 and 5 were collected on a R-AXIS RAPID II
3.2.5. Preparation of complex [(
g
5-C5Me5)Ir(PPh3)(
j
2-Hbsh)]PF6
5
This complex was prepared following the procedure used for 3
using complex 2 in place of 1. 204 mg, 84%. Anal. Calc. for
C42H41N2O2P2IrF6: C, 46.00; H, 4.16; N, 1.66. Found: C, 45.96; H,
4.15; N, 1.68%. 1H NMR (CDCl3, d ppm): 10.37 (s, 1H), 7.71 (s,
1H), 7.5 (s, 1H), 7.4 (s, 1H), 7.31–7.24 (m, 15H, PPh3), 7.06 (d, 1H,
J = 8.1 Hz), 6.69 (t, 2H, J = 7.2 Hz), 6.61 (t, 2H, J = 7.5 Hz), 6.47 (s,
1H), 1.36 (s, 15H, C5Me5). 13C NMR (CDCl3, d ppm): 162.1(free
diffractometer at room temperature with Mo Ka radiation
(k = 0.71073 Å). Structures were solved by direct methods (SHELXS
97) and refined by full-matrix least squares calculations on F2 (SHELX
97) [42]. All the non-H atoms were treated anisotropically.
H-atoms attached to the carbon were included as fixed contribu-
tion and were geometrically calculated and refined using the SHELX
riding model.